arrow
K

Kouji Kobiyama

University of California San Diego
H指数:40
被引数:7,179

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A poorly reactogenic lipid nanoparticle-mRNA vaccine unveils an innate immune pathway for adverse reactions

一种反应原性较差的脂质纳米颗粒-mRNA疫苗揭示不良免疫反应的固有免疫通路

2026-04-160
OAAI
IL-1 delineates squalene-based adjuvant efficacy and reactogenicity in a cell-type-specific manner

IL-1以细胞类型特异性的方式界定了角鲨烯基佐剂的效能和反应原性。

2026-03-300
OAAI
cGAS-IFN-I responses by extracting nuclear DNA from dying cells via nucleocytosis

通过核吞噬作用从死亡细胞中提取核DNA以引发cGAS-IFN-I反应

2026-02-180
OAAI
Long-term immunoprophylaxis by TLR9 ligand mediates macrophage-ILC cross-talk against respiratory viral infection

TLR9配体介导的长期免疫预防通过巨噬细胞-ILC相互作用抵抗呼吸道病毒感染

2026-01-010
PRE
An adjuvant database for preclinical evaluation of vaccines and immunotherapeutics

用于疫苗和免疫治疗药物预临床评价的佐剂数据库

2025-08-110
OAAI
OTUD3 prevents ulcerative colitis by inhibiting microbiota-mediated STING activation

OTUD3通过抑制微生物介导的STING活化来预防溃疡性结肠炎

2025-07-180
PRE
Microbial dysbiosis fuels STING-driven autoinflammation through cyclic dinucleotides

微生物群失调通过环状二核苷酸驱动STING介导的自身炎症。

2025-06-010
OA
Immunological analysis of LC16m8 vaccine: preclinical and early clinical insights into mpox

LC16m8疫苗的免疫学分析:对猴痘的预临床和早期临床见解

2025-05-010
PRE
5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation

5,6-二甲基黄嘌呤酮-4-乙酸 (DMXAA),一种部分STING激动剂,竞争人类STING激活

2024-03-126
OAAI
TLR9 plus STING Agonist Adjuvant Combination Induces Potent Neopeptide T Cell Immunity and Improves Immune Checkpoint Blockade Efficacy in a Tumor Model
2023-12-083
OA